期刊文献+

CTLA-4 siRNA对慢性乙型肝炎患者外周血Th1/Th2细胞因子的影响 被引量:5

Effect of silencing CTLA4 with siRNA on the Th1/Th2 cytokines in peripheral blood of chronic hepatitis B patient
下载PDF
导出
摘要 目的:观察化学合成的小干扰RNA(small interfering RNA,siRNA)对慢性乙型肝炎(chronic hepatitis B,CHB)患者外周血淋巴细胞细胞毒T淋巴细胞相关抗原4(cytotoxic T-lympho-cyte antigen 4,CTLA-4)表达的抑制作用及干扰后对细胞因子IFN-γ、IL-2和IL-4分泌的影响,探讨CTLA-4对慢性乙型肝炎的T细胞免疫调节作用。方法:检测CHB患者外周血淋巴细胞CTLA-4,观察其与HBV-DNA的相关性(P<0.05);根据人淋巴细胞CTLA-4的基因序列,设计合成CTLA-4 siRNA及阴性对照siRNA(siR-NA-co),电穿孔法转染CHB患者外周血淋巴细胞,采用实时荧光定量PCR(real-time Q-PCR)方法检测淋巴细胞CTLA-4 mRNA的表达,采用Western Blotting检测淋巴细胞CTLA-4蛋白表达,采用酶联免疫吸附试验(enzyme-linkedim-muno sorbent assay,ELISA)检测IFN-γ、IL-2和IL-4分泌。结果:CHB患者外周血淋巴细胞CTLA-4表达量与血清HBV-DNA载量有关;CTLA-4 siRNA转染CHB患者外周血淋巴细胞后,CTLA-4 mRNA及CTLA-4蛋白表达均受到抑制,IFN-γ、IL-2分泌增加,与阴性对照相比差异具有统计学意义(P<0.01)。而IL-4分泌没有变化,与阴性对照相比差异没有统计学意义(P>0.05)。结论:CHB患者外周血淋巴细胞CTLA-4表达一定程度抑制免疫反应,利于HBV-DNA的复制;利用siRNA在mRNA水平抑制CHB患者外周血淋巴细胞CTLA-4的表达,能够诱导Th1型细胞因子IL-2、IFN-γ分泌增加,对Th2型细胞因子IL-4无影响。说明抑制CTLA4有助于慢性乙型肝炎患者T细胞免疫的增强。 AIM: To explore the inhibition of expression for cytotoxic T-lymphocyte antigen 4(CTLA-4) in peripheral blood lymphocytes in patients with CHB by chemically synthesized small interfering RNA(siRNA) and the secretion of IFN-γ,IL-2,IL-4,then to analyze the T cellular immune activation by the interference of CTLA-4 gene. METHODS: CTLA-4 of peripheral blood lymphocytes in patients with CHB was detected to observe the correlation with the HBV-DNA;according to human CTAL-4 gene sequence,CTAL-4 siRNA and the negative control(siRNA-co) were designed,synthesized,and then they were transfected into peripheral blood lymphocytes separated from CHB patients by electroporation.The expression of CTLA-4 mRNA was detected by real-time Q-PCR,the CTAL-4 protein was measured by Western Blot and the secretion of IFN-γ,IL-2 and IL-4 were assayed by enzyme-linked immunosorbent assay(ELISA).RESULTS:CTLA-4 of peripheral blood lymphocytes in patients with CHB was correlated to HBV-DNA(P〈0.05);after CTLA-4 were transfected into peripheral blood lymphocytes separated from CHB patients,the expression of CTLA-4 mRNA,CTAL-4 protein were suppressed and the production of IFN-γ,IL-2 were enhanced,compared with the negative control group(P〈0.01),while IL-4 concentrations did not show any significant differences(P〈0.05).CONCLUSION: CTLA-4 of peripheral blood lymphocytes in patients with CHB might contribute to the persistent infection of HBV.Inhibiting the expression of CTLA-4 mRNA in peripheral blood lymphocytes in patients with CHB could up-regulate the secretion of Th1-type cytokines IFN-γ,IL-2 except Th2-type cytokines IL-4.It suggested that inhibiting CTAL-4 is helpful to activating T cellular immunity of patients with CHB.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第5期553-558,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
  • 相关文献

参考文献11

  • 1Bocher WO, Galun E, Marcus H, et al. Reduced hepatitis B virus surface antigen-specific Thl helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen specific antibodies in the trimera mouse [J]. Hepatology, 2000, 31 (2): 480-487.
  • 2Priimiagi LS, Tefanova VT, Tallo TG, et al. Th1-cytokines in chronic hepatitis B and C[J]. Voprosy Virusologii, 2002, 47(3): 23-27.
  • 3June CH, I.edbetter JA, Linsley PS, et al. Role of the CD28 receptor in T-cell activation[J]. Immunol Today, 1990, 11(6): 211-216.
  • 4Sharpe AH, Freeman GJ. The B7-CD28 superfamily [J]. Nat Rev Immunol, 2002, 2(2): 116-126.
  • 5Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA 4[J]. Nat Rev Immunol, 2001, 1(3): 220-228.
  • 6Reuben JM, Lee BN, I.i C, et al. Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma[J]. Cancer, 2006, 106(11): 2437 -2444.
  • 7Annunziato F, Costal L, I.iotta F, et al. Phenotype, localization, and mechanism of suppression of CD4^+CD^25^+ human thymocytes[J]. J Exp Med, 2002, 196(30): 379-383.
  • 8Nasta F, Corinti S, Bonura A, et aI. CTLA-4 regu lates allergen response by modulating GATA-3 pro rein level per cell [J]. Immunology, 2007, 121(1) 62-70.
  • 9Das G, Augustine MM, DasJ, et al. An important regulatory role for CD4^+ CD8 αα T cells in the intestional epithelial layer in the prevention of inflammatory bowel disease[J]. Proc Natl Acad Sci USA, 2003, 100(9): 5324-5329.
  • 10Zhou C, Peng G, Jin X, et al. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine[J]. Clinlmmunol, 2010, 137(2): 190-198.

同被引文献52

  • 1高月求,孙学华,章晓鹰,王灵台,李玉国.不同类型慢性乙肝病毒感染者外周血细胞因子表达的差异[J].胃肠病学和肝病学杂志,2005,14(1):82-83. 被引量:6
  • 2施维群,缪锡民,黄茵,陈智.慢性乙型肝炎患者外周血T细胞标记物表达及细胞因子水平与中医分型的关系[J].世界华人消化杂志,2005,13(11):1364-1367. 被引量:4
  • 3Mageed RA, Prud'homme GJ. Immunopathology and the gene therapy of lupus [J]. Gene Ther, 2003, 10(10): 861--874.
  • 4Herrmann M,Winkler T, Gaipl U, et al. Etiopatho- genesis of systemic lupus erythematosus [J]. Int Arch Allergy Immunol, 2000,123 ( 1 ) : 28 -- 35.
  • 5Riemekasten G, Hahn BH. Key autoatigens in SLE [J]. Rheumatology, 2005,44 (8) : 975 -- 982.
  • 6Jose CC, Vasileios CK, Cox T, et al. T cell as therapeutic target in SLE[J]. Nat Rev Rheumatol, 2010,6~317--325.
  • 7Januchowski R, Wudarski M, Jagodzinski PP, et al. Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression patients with systemic lupus Clin Rheumatol, 2008,27 ( 1 ) : 2 in CD4+ T cells of erythematosus [ J ]. 1--27.
  • 8Nel AE. T-cell activation through the antigen recep tor. Partl: signaling components, signaling path- ways, and signal integration at the T-cell antigen receptor synapse[J]. Clin Immunol, 2002,109 (5) : 758--770.
  • 9Krishnan S, Nambiar MP, Warke VG, et al. Altera- tions in lipid raft composition and dynmics contrib- ute to abnormal T cell responses in systemic lupus erythematosus[J]. J Immunol, 2004,172 ( 12 ) :7821 --7831.
  • 10Deng GM, Tsokos GC. Cholera toxin B accelerates disease progression in lupus-prone mice by promo- ting lipid rah aggregation[J]. J Immunol,2008,181(6):4019--4026.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部